Teva Pharmaceutical Industries's total inventories for the quarter that ended in Mar. 2026 was R$16,609 Mil. Teva Pharmaceutical Industries's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was R$16,976 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Teva Pharmaceutical Industries's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was R$-53.75.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Teva Pharmaceutical Industries's Days Inventory for the
three
months ended in Mar. 2026 was 147.45.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Teva Pharmaceutical Industries's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.62.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Teva Pharmaceutical Industries's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.82.
Teva Pharmaceutical Industries (BSP:T1EV34) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Teva Pharmaceutical Industries's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Teva Pharmaceutical Industries's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Teva Pharmaceutical Industries Total Inventories Related Terms
Teva Pharmaceutical Industries Total Inventories Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teva Pharmaceutical Industries Total Inventories Chart
Teva Pharmaceutical Industries Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
What does a Total Inventories of R$16,609 Mil mean?
Teva Pharmaceutical Industries (BSP:T1EV34) has a Total Inventories of R$16,609 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Teva Pharmaceutical Industries and its competitors.
Is Teva Pharmaceutical Industries' Total Inventories too high?
Teva Pharmaceutical Industries' current Total Inventories is R$16,609 Mil. Overall, Teva Pharmaceutical Industries has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Teva Pharmaceutical Industries' Total Inventories compare to ZTS and UTHR?
Teva Pharmaceutical Industries' Total Inventories of R$16,609 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Drug Manufacturers company?
A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Teva Pharmaceutical Industries and its competitors. Teva Pharmaceutical Industries's current Total Inventories is R$16,609 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teva Pharmaceutical Industries stock overvalued right now?
Teva Pharmaceutical Industries (BSP:T1EV34) has a current Total Inventories of R$16,609 Mil. The stock's GF Value™ is R$53.50, compared to a current price of R$85.99 — trading 60.7% above its estimated fair value. The current Total Inventories is R$16,609 Mil. Teva Pharmaceutical Industries' overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Teva Pharmaceutical Industries (BSP:T1EV34), the current Total Inventories is R$16,609 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Teva Pharmaceutical Industries (BSP:T1EV34) Overvalued in 2026?
Based on GuruFocus' analysis, Teva Pharmaceutical Industries stock appears to be overvalued.
The current stock price of R$85.99 is trading 60.7% above its estimated GF Value™ of R$53.50.
Key valuation signals for BSP:T1EV34:
Total Inventories: R$16,609 Mil
GF Value™: R$53.50 vs. price of R$85.99 (60.7% above fair value)
No single metric tells the full story. See the BSP:T1EV34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Teva Pharmaceutical Industries Business Description
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
59GF Score
Get the complete analysis for BSP:T1EV34
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:T1EV34 has been successfully added to your 
